OBJECTIVE: Although brain radiation therapy (RT) impacts cognitive function, little is known about the subset of survivors with minimal cognitive deficits. This study compares the characteristics of patients receiving brain irradiation as part of cancer treatment with minimal cognitive deficits to those with poorer cognitive functioning. METHODS: Adults at least 6 months postbrain RT (N = 198) completed cognitive measures of attention, memory, and executive functions. Cognitive functioning was categorized into better- and poorer-performing groups, with better-performing survivors scoring no worse than 1.5 standard deviations below the published normative mean on all cognitive measures. Logistic regression was used to identify variables associated with better-performing group membership. RESULTS: Approximately 25% of the sample met the criteria for the better-performing group. In unadjusted analyses, RT type (whole brain irradiation and partial brain irradiation), sedating medications, and fatigue were independently associated with cognition. Sociodemographic and other clinical characteristics were not significant. In adjusted analyses, only fatigue remained significantly associated with group membership (OR = 1.05, 95% CI = 1.01-1.09, P = .009). CONCLUSIONS: There is a subgroup of survivors with minimal long-term cognitive deficits despite undergoing a full course of brain RT as part of cancer treatment. Lower fatigue had the strongest association with better cognitive performance. Interventions targeting cancer-related fatigue may help buffer the neurotoxic effects of brain RT.
OBJECTIVE: Although brain radiation therapy (RT) impacts cognitive function, little is known about the subset of survivors with minimal cognitive deficits. This study compares the characteristics of patients receiving brain irradiation as part of cancer treatment with minimal cognitive deficits to those with poorer cognitive functioning. METHODS: Adults at least 6 months postbrain RT (N = 198) completed cognitive measures of attention, memory, and executive functions. Cognitive functioning was categorized into better- and poorer-performing groups, with better-performing survivors scoring no worse than 1.5 standard deviations below the published normative mean on all cognitive measures. Logistic regression was used to identify variables associated with better-performing group membership. RESULTS: Approximately 25% of the sample met the criteria for the better-performing group. In unadjusted analyses, RT type (whole brain irradiation and partial brain irradiation), sedating medications, and fatigue were independently associated with cognition. Sociodemographic and other clinical characteristics were not significant. In adjusted analyses, only fatigue remained significantly associated with group membership (OR = 1.05, 95% CI = 1.01-1.09, P = .009). CONCLUSIONS: There is a subgroup of survivors with minimal long-term cognitive deficits despite undergoing a full course of brain RT as part of cancer treatment. Lower fatigue had the strongest association with better cognitive performance. Interventions targeting cancer-related fatigue may help buffer the neurotoxic effects of brain RT.
Authors: Kala M Mehta; Eleanor M Simonsick; Ronica Rooks; Anne B Newman; Sandra K Pope; Susan M Rubin; Kristine Yaffe Journal: J Am Geriatr Soc Date: 2004-12 Impact factor: 5.562
Authors: Katherine B Peters; Miranda J West; Whitney E Hornsby; Emily Waner; April D Coan; Frances McSherry; James E Herndon; Henry S Friedman; Annick Desjardins; Lee W Jones Journal: J Neurooncol Date: 2014-08-13 Impact factor: 4.130
Authors: Dorothy Krolak; Barbara Collins; Lorelle Weiss; Cheryl Harris; Richard Van der Jagt Journal: Support Care Cancer Date: 2016-11-11 Impact factor: 3.603
Authors: Oana C Lindner; Bob Phillips; Martin G McCabe; Andrew Mayes; Alison Wearden; Filippo Varese; Deborah Talmi Journal: Neuropsychology Date: 2014-03-17 Impact factor: 3.295
Authors: Emma van Kessel; Anniek E Baumfalk; Martine J E van Zandvoort; Pierre A Robe; Tom J Snijders Journal: J Neurooncol Date: 2017-05-31 Impact factor: 4.130
Authors: Sarah E MacPherson; Colm Healy; Michael Allerhand; Barbara Spanò; Carina Tudor-Sfetea; Mark White; Daniela Smirni; Tim Shallice; Edgar Chan; Marco Bozzali; Lisa Cipolotti Journal: Neuropsychologia Date: 2016-12-29 Impact factor: 3.139
Authors: Kevin M Pantalone; Todd M Hobbs; Kevin M Chagin; Sheldon X Kong; Brian J Wells; Michael W Kattan; Jonathan Bouchard; Brian Sakurada; Alex Milinovich; Wayne Weng; Janine Bauman; Anita D Misra-Hebert; Robert S Zimmerman; Bartolome Burguera Journal: BMJ Open Date: 2017-11-16 Impact factor: 2.692
Authors: Michelle J Naughton; L Douglas Case; Ann Peiffer; Michael Chan; Volker Stieber; Dennis Moore; Steven Falchuk; James Piephoff; William Edenfield; Jeffrey Giguere; Monica Loghin; Edward G Shaw; Stephen R Rapp Journal: Neurooncol Pract Date: 2017-07-06
Authors: Fariba Tohidinezhad; Dario Di Perri; Catharina M L Zegers; Jeanette Dijkstra; Monique Anten; Andre Dekker; Wouter Van Elmpt; Daniëlle B P Eekers; Alberto Traverso Journal: Front Psychol Date: 2022-03-31